Trials / Recruiting
RecruitingNCT04419480
Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Inova Health Care Services · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Pilot Prospective Randomized Unblinded Pragmatic Trial of Pulmonary Artery Hemodynamic Monitoring Following Hospitalization for Cardiogenic Shock
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | CardioMEMS implantation with routine ambulatory pulmonary artery pressure monitoring and medication optimization | Implantation of CardioMEMS Device in patients following admission for Cardiogenic shock, with regular ambulatory pulmonary artery pressure monitoring and medication optimization for the treatment of heart failure. |
Timeline
- Start date
- 2020-12-31
- Primary completion
- 2028-12-31
- Completion
- 2028-12-31
- First posted
- 2020-06-05
- Last updated
- 2026-03-16
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04419480. Inclusion in this directory is not an endorsement.